2026. EVALUATING HEMATOLOGICAL AND INFLAMMATORY BIOMARKERS IN TUBERCULOSIS MANAGEMENT. Review Journal of Neurological & Medical Sciences Review. 4, 5 (May 2026), 249–258. DOI:https://doi.org/10.63075/vk86y572.